Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Embolism, Air | 1 | 2018 | 23 | 0.72 | Why? |
| Biopsy, Needle | 1 | 2018 | 303 | 0.65 | Why? |
| Pulmonary Disease, Chronic Obstructive | 8 | 2019 | 3832 | 0.58 | Why? |
| Respiratory Therapy | 1 | 2018 | 918 | 0.45 | Why? |
| Forced Expiratory Volume | 6 | 2018 | 632 | 0.42 | Why? |
| Pulmonary Medicine | 3 | 2021 | 706 | 0.40 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.37 | Why? |
| Austria | 6 | 2021 | 1259 | 0.32 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.19 | Why? |
| Bronchitis, Chronic | 1 | 2017 | 15 | 0.18 | Why? |
| Image-Guided Biopsy | 1 | 2018 | 185 | 0.16 | Why? |
| Nebulizers and Vaporizers | 1 | 2018 | 497 | 0.14 | Why? |
| Altitude | 1 | 2017 | 311 | 0.13 | Why? |
| Fluorodeoxyglucose F18 | 2 | 2018 | 1153 | 0.12 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.12 | Why? |
| Exercise Tolerance | 1 | 2017 | 634 | 0.12 | Why? |
| Multimodal Imaging | 1 | 2016 | 534 | 0.11 | Why? |
| Cardiomyopathies | 1 | 2020 | 997 | 0.11 | Why? |
| Tuberculosis | 2 | 2018 | 2895 | 0.11 | Why? |
| Positron-Emission Tomography | 1 | 2016 | 802 | 0.10 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.09 | Why? |
| Diabetes Mellitus | 2 | 2020 | 8207 | 0.08 | Why? |
| Quality of Life | 2 | 2018 | 9820 | 0.08 | Why? |
| Lung Diseases | 1 | 2020 | 2361 | 0.08 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Skin Diseases | 1 | 2021 | 2509 | 0.07 | Why? |
| Oxygen Inhalation Therapy | 1 | 2017 | 3629 | 0.07 | Why? |
| Spirometry | 2 | 2017 | 524 | 0.07 | Why? |
| Aged | 13 | 2020 | 215776 | 0.07 | Why? |
| Tomography, X-Ray Computed | 3 | 2020 | 25144 | 0.06 | Why? |
| Bronchodilator Agents | 2 | 2018 | 444 | 0.06 | Why? |
| Asthma | 1 | 2021 | 4383 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Male | 13 | 2020 | 367725 | 0.05 | Why? |
| Budesonide | 1 | 2021 | 192 | 0.05 | Why? |
| Europe, Eastern | 1 | 2018 | 88 | 0.05 | Why? |
| Lung | 2 | 2018 | 31049 | 0.05 | Why? |
| Middle Aged | 12 | 2020 | 270681 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.04 | Why? |
| Humans | 21 | 2021 | 930598 | 0.04 | Why? |
| Female | 13 | 2020 | 380317 | 0.04 | Why? |
| Biological Transport | 1 | 2018 | 290 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Disability Evaluation | 1 | 2020 | 671 | 0.04 | Why? |
| Vital Capacity | 1 | 2017 | 399 | 0.04 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.03 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.03 | Why? |
| Smoking | 2 | 2017 | 3358 | 0.03 | Why? |
| Cough | 2 | 2017 | 4891 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Colombia | 1 | 2017 | 1241 | 0.03 | Why? |
| Respiration | 1 | 2017 | 729 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2018 | 1647 | 0.03 | Why? |
| Latin America | 1 | 2017 | 1721 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Belgium | 1 | 2017 | 2064 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Radiopharmaceuticals | 1 | 2016 | 763 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.03 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2017 | 1530 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Adult | 6 | 2020 | 244371 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Chronic Disease | 1 | 2020 | 5139 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Schools | 1 | 2021 | 4187 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.02 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.02 | Why? |
| Myocarditis | 1 | 2020 | 2731 | 0.02 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.02 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.02 | Why? |
| International Cooperation | 1 | 2017 | 3436 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Risk Factors | 2 | 2019 | 71621 | 0.01 | Why? |
| Spain | 1 | 2017 | 15545 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
Lamprecht's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(222)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_